X
VCYT icon

Xponance’s Veracyte VCYT Stock Holding History

Xponance’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Sell
8,040
-46
-0.6% -$1.93K ﹤0.01% 1128
2026
Q1 		$260K Buy
8,086
+1,215
+18% +$45K ﹤0.01% 1354
2025
Q4 		$289K Buy
6,871
+741
+12% +$29.9K ﹤0.01% 1203
2025
Q3 		$210K Buy
+6,130
New +$176K ﹤0.01% 1345
2025
Q2 		– Sell
-6,860
Closed -$203K – 1543
2025
Q1 		$203K Buy
6,860
+370
+6% +$14.1K ﹤0.01% 1266
2024
Q4 		$257K Buy
+6,490
New +$246K ﹤0.01% 1179

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Xponance's VCYT Position: Q2 2026 in Review

Xponance reduced its Veracyte (VCYT) stake by 0.57% in Q2 2026, selling an estimated $1.93K and leaving 8,040 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Xponance first reported a position in VCYT in Q4 2024 and has held it in 6 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Xponance held 8,040 shares of Veracyte worth $472K as of Q2 2026.
  • Xponance sold 46 Veracyte shares in Q2 2026, an estimated $1.93K.
  • Veracyte made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1128 holding.
  • Xponance first reported a position in Veracyte in Q4 2024 and has held it in 6 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.